Aurenar’s V-Link system uses transauricular vagus nerve stimulation to modulate brain inflammation in patients that have ...

Ischemic stroke is the second leading cause of death globally and the primary cause of death in China. Over the past two decades, Prof. Hongbin Han's team has been committed to advancing diagnosis and ...

Given the size of the stroke depicted in Figure 1 (greater than one third of the hemisphere), thrombolytic therapy would be contraindicated for this patient. Indications of a hemorrhagic stroke ...

Ischemic stroke is a leading cause of death and disability, affecting about 15 million worldwide each year. Among the various factors contributing to the pathogenesis of this condition is the loss of ...

By tamping down metabolism, a new experimental treatment that induces a hypothermia-like state may slow stroke-associated ...

When a person suffers a stroke, physicians must restore blood flow to the brain as quickly as possible to save their life. But, ironically, that life-saving rush of blood can also trigger a second ...

Time is of the essence in establishing the diagnosis of stroke and determining whether the patient is a candidate for thrombolytic therapy, ideally initiated within the “golden hour” after arrival at ...